Sarah Wall

3.0k total citations
54 papers, 250 citations indexed

About

Sarah Wall is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Sarah Wall has authored 54 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 16 papers in Oncology and 14 papers in Genetics. Recurrent topics in Sarah Wall's work include Acute Myeloid Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Frailty in Older Adults (10 papers). Sarah Wall is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Frailty in Older Adults (10 papers). Sarah Wall collaborates with scholars based in United States, Italy and Australia. Sarah Wall's co-authors include Ashley Rosko, Carolyn J. Presley, Edmund Folefac, Sumithira Vasu, Steven M. Devine, Alice S. Mims, Nicole Williams, Janine Overcash, Anne M. Noonan and Jessica L. Krok‐Schoen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sarah Wall

44 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Wall United States 9 98 80 61 54 54 54 250
Ignacio Gómez‐Centurión Spain 11 102 1.0× 84 1.1× 22 0.4× 21 0.4× 54 1.0× 27 231
Hironori Takeuchi Japan 9 10 0.1× 47 0.6× 63 1.0× 15 0.3× 65 1.2× 28 309
C. K. Daugherty United States 6 160 1.6× 52 0.7× 138 2.3× 4 0.1× 41 0.8× 13 341
Katie S. Gatwood United States 8 83 0.8× 111 1.4× 23 0.4× 30 0.6× 20 0.4× 33 255
Ghada Elgohary Egypt 10 110 1.1× 139 1.7× 50 0.8× 2 0.0× 36 0.7× 31 298
Almuth Klippstein Germany 5 61 0.6× 140 1.8× 68 1.1× 134 2.5× 3 0.1× 5 311
Sandra Malak France 9 62 0.6× 52 0.7× 37 0.6× 3 0.1× 33 0.6× 18 302
Elizabeth F. Krakow United States 10 145 1.5× 81 1.0× 71 1.2× 47 0.9× 36 321
Richard K. Leuchter United States 8 11 0.1× 34 0.4× 28 0.5× 4 0.1× 57 1.1× 18 194
Céline Desconclois France 8 101 1.0× 33 0.4× 57 0.9× 64 1.2× 17 295

Countries citing papers authored by Sarah Wall

Since Specialization
Citations

This map shows the geographic impact of Sarah Wall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Wall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Wall more than expected).

Fields of papers citing papers by Sarah Wall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Wall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Wall. The network helps show where Sarah Wall may publish in the future.

Co-authorship network of co-authors of Sarah Wall

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Wall. A scholar is included among the top collaborators of Sarah Wall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Wall. Sarah Wall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wall, Sarah, Sam Penza, Kevin K.W. Ho, et al.. (2025). Axatilimab Combination Therapies with Ruxolitinib and/or Belumosudil Induces Clinical Responses in Patients with Severe, Treatment-Refractory Chronic Gvhd. Transplantation and Cellular Therapy. 31(2). S82–S83.
2.
Patnaik, Mrinal M., Haris Ali, Eunice S. Wang, et al.. (2025). Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study. PubMed. 2(4). 100115–100115.
3.
4.
Bhatt, Neel S., Yvonne A. Efebera, Steven M. Devine, et al.. (2025). Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice. Blood Advances. 9(17). 4448–4457. 1 indexed citations
5.
Auletta, Jeffery J., Jennifer Holter‐Chakrabarty, Pashna N. Munshi, et al.. (2024). Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and Cellular Therapy. 30(12). 1124–1138. 2 indexed citations
6.
Silberman, Pedro C., Yazeed Sawalha, Beth Christian, et al.. (2024). Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL).. Journal of Clinical Oncology. 42(16_suppl). 7033–7033. 2 indexed citations
7.
Jiang, Justin, Audrey M. Sigmund, Qiuhong Zhao, et al.. (2024). Impact of chronic graft- versus -host disease on non-relapse mortality and survival. Leukemia & lymphoma. 65(11). 1698–1705. 1 indexed citations
8.
Wall, Sarah, Sumithira Vasu, Sam Penza, et al.. (2024). Real-World Clinical Outcomes of Severe, Treatment-Refractory Chronic Gvhd Patients Treated with Axatilimab Combination Therapies. Blood. 144(Supplement 1). 7362–7362. 1 indexed citations
9.
Kaffenberger, Benjamin H., Catherine Chung, Eric Samorodnitsky, et al.. (2024). Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib. Haematologica. 109(11). 3816–3820. 1 indexed citations
10.
Wall, Sarah, Ying Huang, Edmund Folefac, et al.. (2023). Slow and Steady Wins the Race: Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Candidates. Blood. 142(Supplement 1). 2432–2432.
11.
Jamy, Omer, Margaret Kasner, Sarah Wall, et al.. (2023). Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions. Leukemia Research. 134. 107393–107393. 2 indexed citations
12.
Wall, Sarah, Rebecca L. Olin, Vijaya Raj Bhatt, et al.. (2023). The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients. Transplantation and Cellular Therapy. 29(10). 632.e1–632.e10. 8 indexed citations
13.
DeFilipp, Zachariah, Haesook T. Kim, Laura Knight, et al.. (2022). Prolonged Post-Transplant Ruxolitinib Therapy is Associated with Protection from Severe Gvhd after Allogeneic HCT. Transplantation and Cellular Therapy. 28(3). S305–S306. 2 indexed citations
14.
Wall, Sarah, Ying Huang, Carolyn J. Presley, et al.. (2021). Increasing Number of Geriatric Assessment-Identified Deficits Associated with Non-Receipt of Transplant Among Older Adults. Transplantation and Cellular Therapy. 27(3). S437–S438. 1 indexed citations
15.
Zhao, Qiuhong, Patrick Elder, Jonathan E. Brammer, et al.. (2020). Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS. Leukemia & lymphoma. 62(4). 944–951. 5 indexed citations
16.
Rubinstein, Samuel M., Ryan C. Lynch, Aakash Desai, et al.. (2020). Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis. Blood. 136(Supplement 1). 28–30. 7 indexed citations
17.
Huang, Ying, James S. Blachly, Nicole R. Grieselhuber, et al.. (2020). The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating Agent. Clinical Lymphoma Myeloma & Leukemia. 21(1). e76–e83. 4 indexed citations
18.
Wall, Sarah, Steven M. Devine, & Sumithira Vasu. (2017). The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60 years. Blood Reviews. 31(6). 362–369. 14 indexed citations
19.
Jordan, Kim, et al.. (2015). Associations with resuscitation choice: Do not resuscitate, full code or undecided. Patient Education and Counseling. 99(5). 823–829. 10 indexed citations
20.
Wall, Sarah & Jennifer A. Woyach. (2015). Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders. Clinics in Geriatric Medicine. 32(1). 175–189. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignacio Gómez‐Centurión Breakdown of academic impact, for papers by Hironori Takeuchi Breakdown of academic impact, for papers by C. K. Daugherty Breakdown of academic impact, for papers by Katie S. Gatwood Breakdown of academic impact, for papers by Ghada Elgohary Breakdown of academic impact, for papers by Almuth Klippstein Breakdown of academic impact, for papers by Sandra Malak Breakdown of academic impact, for papers by Elizabeth F. Krakow Breakdown of academic impact, for papers by Richard K. Leuchter Breakdown of academic impact, for papers by Céline Desconclois
Rankless by CCL
2026